In synucleinopathy models, both in vivo and in vitro studies showed that TREM2 deficiency increases microglia activation during α-syn-induced inflammatory processes, leading to an increased loss of dopaminergic neurons (53% vs. 28% after 3 weeks) in animal models [24]. Here, TREM2 is linked to synucleinopathy.